tiprankstipranks
Resmed (MX:RMD)
:RMD
Mexico Market
RMD
Resmed
RESEARCH TOOLSreports

Resmed (RMD) Ratios

2 Followers

Resmed Ratios

MX:RMD's free cash flow for Q4 2026 was $0.59. For the 2026 fiscal year, MX:RMD's free cash flow was decreased by $ and operating cash flow was $0.32. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 3.10 3.10 3.44 2.59 3.12
Quick Ratio
 2.42 2.42 2.53 1.69 1.81
Cash Ratio
 1.05 1.05 1.19 0.26 0.30
Solvency Ratio
 0.72 0.72 0.74 0.62 0.42
Operating Cash Flow Ratio
 2.26 1.29 1.72 1.54 0.91
Short-Term Operating Cash Flow Coverage
 12.14 6.95 176.93 141.54 70.02
Net Current Asset Value
$ 1.94B$ 1.94B$ 1.30B$ 349.37M$ -253.97M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.09 0.10 0.13 0.23
Debt-to-Equity Ratio
 0.13 0.13 0.14 0.18 0.38
Debt-to-Capital Ratio
 0.11 0.11 0.12 0.15 0.28
Long-Term Debt-to-Capital Ratio
 0.06 0.06 0.10 0.13 0.26
Financial Leverage Ratio
 1.36 1.36 1.37 1.41 1.63
Debt Service Coverage Ratio
 6.06 6.06 72.71 23.19 20.16
Interest Coverage Ratio
 65.20 65.20 133.66 28.88 23.89
Debt to Market Cap
 0.02 0.02 0.02 0.03 0.04
Interest Debt Per Share
 5.91 5.91 5.89 6.26 11.09
Net Debt to EBITDA
 -0.30 -0.30 -0.19 0.41 1.00
Profitability Margins
Gross Profit Margin
61.16%61.16%59.36%56.67%55.78%
EBIT Margin
34.46%34.46%32.60%27.97%27.52%
EBITDA Margin
37.96%37.96%37.18%32.73%32.18%
Operating Profit Margin
33.48%33.48%32.75%28.17%26.80%
Pretax Profit Margin
33.95%33.95%32.60%27.00%26.09%
Net Profit Margin
26.94%26.94%27.22%21.79%21.25%
Continuous Operations Profit Margin
26.94%26.94%27.22%21.79%21.25%
Net Income Per EBT
79.36%79.36%83.50%80.72%81.47%
EBT Per EBIT
101.41%101.41%99.54%95.83%97.33%
Return on Assets (ROA)
16.99%16.99%17.14%14.86%13.29%
Return on Equity (ROE)
23.88%23.13%23.47%20.99%21.73%
Return on Capital Employed (ROCE)
25.00%25.00%23.55%22.14%18.89%
Return on Invested Capital (ROIC)
19.11%19.11%19.56%17.77%15.31%
Return on Tangible Assets
27.18%27.18%30.04%28.80%26.17%
Earnings Yield
4.61%5.40%3.70%3.71%2.80%
Efficiency Ratios
Receivables Turnover
 5.46 5.46 5.19 5.60 5.99
Payables Turnover
 7.11 7.11 7.52 8.54 12.39
Inventory Turnover
 2.32 2.32 2.25 2.47 1.87
Fixed Asset Turnover
 7.69 7.69 7.16 6.70 6.34
Asset Turnover
 0.63 0.63 0.63 0.68 0.63
Working Capital Turnover Ratio
 2.00 2.09 2.62 3.07 2.96
Cash Conversion Cycle
 172.77 172.77 183.63 170.33 226.54
Days of Sales Outstanding
 66.90 66.90 70.26 65.23 60.93
Days of Inventory Outstanding
 157.22 157.22 161.91 147.84 195.08
Days of Payables Outstanding
 51.35 51.35 48.55 42.74 29.47
Operating Cycle
 224.12 224.12 232.17 213.07 256.00
Cash Flow Ratios
Operating Cash Flow Per Share
 21.82 12.48 11.94 9.53 4.72
Free Cash Flow Per Share
 19.97 11.40 11.33 8.75 3.81
CapEx Per Share
 1.85 1.08 0.61 0.78 0.91
Free Cash Flow to Operating Cash Flow
 0.92 0.91 0.95 0.92 0.81
Dividend Paid and CapEx Coverage Ratio
 3.59 3.57 4.37 3.53 1.77
Capital Expenditure Coverage Ratio
 11.80 11.55 19.49 12.20 5.17
Operating Cash Flow Coverage Ratio
 3.82 2.19 2.06 1.60 0.44
Operating Cash Flow to Sales Ratio
 0.56 0.32 0.34 0.30 0.16
Free Cash Flow Yield
8.72%5.85%4.39%4.68%1.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 21.87 18.67 27.02 26.92 35.73
Price-to-Sales (P/S) Ratio
 5.86 4.99 7.36 5.87 7.59
Price-to-Book (P/B) Ratio
 5.02 4.28 6.34 5.65 7.76
Price-to-Free Cash Flow (P/FCF) Ratio
 11.46 17.10 22.78 21.37 57.34
Price-to-Operating Cash Flow Ratio
 10.47 15.62 21.61 19.61 46.25
Price-to-Earnings Growth (PEG) Ratio
 2.35 2.00 0.72 2.01 2.45
Price-to-Fair Value
 5.02 4.28 6.34 5.65 7.76
Enterprise Value Multiple
 15.13 12.84 19.60 18.34 24.60
Enterprise Value
 32.48B 27.56B 37.50B 28.12B 33.42B
EV to EBITDA
 15.13 12.84 19.60 18.34 24.60
EV to Sales
 5.75 4.87 7.29 6.00 7.91
EV to Free Cash Flow
 11.24 16.71 22.56 21.86 59.75
EV to Operating Cash Flow
 10.29 15.26 21.41 20.07 48.20
Tangible Book Value Per Share
 22.27 22.27 16.74 10.45 5.50
Shareholders’ Equity Per Share
 45.51 45.51 40.68 33.08 28.14
Tax and Other Ratios
Effective Tax Rate
 0.21 0.21 0.17 0.19 0.19
Revenue Per Share
 39.07 39.07 35.08 31.87 28.77
Net Income Per Share
 10.53 10.53 9.55 6.94 6.12
Tax Burden
 0.79 0.79 0.83 0.81 0.81
Interest Burden
 0.99 0.99 1.00 0.97 0.95
Research & Development to Revenue
 0.07 0.07 0.06 0.07 0.07
SG&A to Revenue
 0.14 0.14 0.19 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.02 0.02 0.02 0.02
Income Quality
 1.19 1.19 1.25 1.37 0.77
Currency in USD